je.st
news
Bristol 2Q net drops on lower drug sales, charges
2014-07-24 16:50:44| Biotech - Topix.net
Bristol-Myers Squibb Co.' s exit from the diabetes business, plus higher taxes and research spending, combined to slash the drugmaker's second-quarter profit by 38 percent, but the company handily beat Wall Street's muted profit expectations.
Tags: net
sales
lower
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||